Showing results (1511-1520 of 4,138) with videos related to

Sort By:
Pageof 414
Human Gene Therapy|February 24, 1998
Delivery of recombinant gene product to canines with nonautologous microencapsulated cellsM A Peirone, K Delaney, J Kwiecin, et al.
Human Gene Therapy|February 24, 1998
Efficient transduction of hemopoietic CD34+ progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29: in vitro assessmentO Cohen-Haguenauer, L M Restrepo, M Masset, et al.
Human Gene Therapy|February 24, 1998
Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibodyH Konishi, T Ochiya, K A Chester, et al.
Human Gene Therapy|June 2, 1998
Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cellsG Maass, C Bogedain, U Scheer, et al.
Human Gene Therapy|April 3, 1998
Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graftS A Eming, D A Medalie, R G Tompkins, et al.
Human Gene Therapy|June 13, 1998
Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma modelJ G Turner, J Tan, B E Crucian, et al.
Human Gene Therapy|June 13, 1998
Murine bone marrow expressing the neomycin resistance gene has no competitive disadvantage assessed in vivoT Wu, M L Bloom, J M Yu, et al.
Human Gene Therapy|June 13, 1998
Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genesM Suzuki, R Singh, M A Moore, et al.
Human Gene Therapy|April 28, 2015
The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical PerspectiveCarl Hayward, Nicholas R Banner, Andrew Morley-Smith, et al.
Human Gene Therapy|April 29, 2015
(211)Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene TherapyChristopher R Burtner, Devikha Chandrasekaran, Erlinda B Santos, et al.
Pageof 414